Autor: christine.stump@joimax.com

joimax® Launches NAVENTO® Navigation Endoscopic Tower at NASS and EUROSPINE

Veröffentlicht am von christine.stump@joimax.com

IRVINE, CA – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the global launch of its new generation tower, NAVENTO® Navigation Endoscopic Tower. Optimized for endoscopic spine surgery with special settings for the safe treatment of sensitive structures, NAVENTO® will be featured at the North American Spine Society (NASS) meeting in Boston later this month and at EUROSPINE in Vienna this October.

joimax endoscopic tower NAVENTO

NAVENTO®, the fully integrated fourth generation endo-tower, contains everything a surgeon needs to perform a successful procedure. The tower boasts updated design features for enhanced usability and is composed of six devices that work in unison to give the user the best possible surgical experience:

  1. Vitegra®, the brain of NAVENTO®, offers complete documentation and data management.
  2. Camsource® LED provides optimal clarity up to 4K resolution.
  3. Intracs®, the newest device from joimax®, delivers electromagnetic navigation at the instrument’s tip.
  4. Shrill®, the shaver drill system, with the newest generation recently launched, provides optimal RPMs and torque management.
  5. Endovapor® 2 poses electrosurgical offerings for monopolar and bipolar settings.
  6. Versicon®, delivers fluid and pressure regulation.

“joimax® continues to lead the endoscopic spine market through innovations in technologies aimed to increase the user experience and provide spinal patients with an ultra-minimally invasive treatment option,” stated Christoph Hofstetter, M.D., Ph.D., associate professor in the Department of Neurological Surgery at the University of Washington.

Wolfgang Ries, CEO and founder of the joimax® group, confirmed, “NAVENTO® pulls together the latest technologies forming one complete, seamlessly integrated spinal endoscopic package.”

NAVENTO®, along with the full suite of joimax® endoscopic technologies will be showcased at NASS, booth #3512, and at EUROSPINE, booth #04.

joimax® announces 510(k) clearance for its Endovapor® 2 Multi Radio Frequency System with its first presentation at the Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS) 2017, in Los Angeles

Veröffentlicht am von christine.stump@joimax.com

Irvine, CA – April 26, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Endovapor® 2 Multi Radio Frequency System.

The patented device generates electrical power for monopolar and bipolar cutting and coagulation of tissue structures in surgical operations. The joimax® Endovapor® 2 is an all-in-one generator with specially integrated programs for spinal surgery with interdisciplinary application. The device is equipped with two monopolar and two bipolar sockets and an easy and intuitive touchpad technology. With arc control for safe application and easy neutral electrode monitoring, it combines a variety of different electro-surgical modes and effects.

“After receiving the FDA clearance for the joimax® Vaporflex® and Legato® electrosurgical probes in early  November 2016, this is another milestone in strengthening the joimax® position as an expert in endoscopic minimally invasive spine surgery,” states Wolfgang Ries, Founder and CEO of joimax®.

During the AANS, joimax®  participated in the CME endoscopic cadaveric workshop with two stations and held a very successful US-expert meeting including topics such as training procedures, clinical Research and future technologies.

joimax® celebrates 10 successful years on the market with TESSYS® at the WCMISST in Paris

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, 11.06.2014. joimax® looks back on 10 years of success with the surgical application of TESSYS® for the minimally invasive, endoscopic removal of herniated discs; a particularly gentle surgical technique which utilizes the natural transforaminal access to the spinal canal. TESSYS® was the first product that brought joimax® to market and was a breakthrough for the company. Today, joimax® offers a highly diversified product portfolio for 360° surgery in almost all areas of the spine including endoscopic and percutaneous stabilization.

During the award ceremony in Paris, two TESSYS® pioneers will be awarded with the “Parviz Kambin Honorary Award”: Dr. Florian Maria Alfen of Würzburg, who bought the very first TESSYS® system in 2004 and has successfully operated on more than 2,500 patients. As a member of the joimax® Faculty Team, Dr. Alfen has trained a large number of surgeons. The second award winner is Dr. Daniel Laich of Chicago. He is the very first TESSYS® user in the U.S. and has been a faculty member since 2009. Since 2013, he has also been operating as a scientific advisor for the company.

Since 2004, more than 100,000 patients in 30 countries were surgically treated with the TESSYS® method and its subsequent surgical developments. Follow-up studies show a significantly shorter recovery time, faster return to work and normal activities with improved quality of life and ultimately, lower costs to the social system.

At the WCMISST, the 4th World Congress of Minimally Invasive Spine Surgery and Techniques, joimax® presents its latest development- the EndoLIF® system for endoscopic stabilization of the lumbar spine. Aside from fully endoscopic access via the proven TESSYS® and iLESSYS® methods, the EndoLIF® system contains an O-Cage for oblique interbody fusion. In addition, joimax® presents its new Percusys® System- a posterior, percutaneous screw and rod system. The advantages of these products and procedures are apparent:

– Smooth, atraumatic access due to gentle dilation of tissue
– Dura and nerves are protected by the working tubes
– Dorsal bone structures are generally not affected and remain intact
– O-Cage with an osteo-conductive surface provides the optimum substrate for cellular growth
– Posterior, percutaneous stabilization via the minimally invasive screw and rod system

Both of these systems are CE marked and FDA clearance is in progress.

Visit us at WCMISST, booth #15 at the Marriott Rive Gauche Hotel and discover for yourself the many advantages of our newest systems.

Collage_WC_MISST_Paris_2014_med

joimax® obtains registration for all products in the Indian market

Veröffentlicht am von christine.stump@joimax.com

KARLSRUHE, Germany–(BUSINESS WIRE)–German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce the full registration of all its products for India, one of the fastest growing endoscopic spine surgery markets worldwide.

The Indian registration includes all joimax® Class II and III, as well as Class I instruments, which were approved in 2023. Now, the Indian health community has access to all the latest spinal endoscopic technologies invented, developed and manufactured by joimax®.

“India is the biggest country in the world; it’s ready for emerging technology businesses like endoscopic spinal surgery,” states Santhosh Mechery, Director Spectramed Healthcare (P) Ltd. “We can’t wait to roll-out the complete joimax® portfolio in our country and enable so many patients to profit from this innovative, minimally invasive endoscopic spine surgery.”

“Earlier this year, joimax® received its CE MDR approvals, granted by TÜV-South — an important step for marketing our existing products under the new European regulation, which opened a backlog of products to India,” states joimax® Founder and CEO Wolfgang Ries. “We’re already active in more than 60 countries! These partners are eager to launch the newest joimax® treatment technologies.”

In Fall 2022, joimax®, in cooperation with Spectramed Healthcare, launched its education and training program, Endoscopic Spine Academy (ESPINEA®), in India, which has since been rolled out worldwide. ESPINEA® was founded in 2019, accredited by the Royal College of Surgeons of Edinburgh in 2020, and this year, is celebrating its 5th anniversary. The program allows for the highest quality training of joimax® products in any market, serving as a hands-on learning facility for endoscopic spinal surgery.

Veröffentlicht in Allgemein

New partnership: joimax® joins forces with JAPAN MEDICALNEXT CO., LTD.

Veröffentlicht am von christine.stump@joimax.com

(Karlsruhe-GER, 16 June 2020)

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

“joimax® is looking forward to working with a partner strong as JMC, says joimax® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax® products in Japan”. Thus, joimax® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

CMS Includes Endoscopic Spine in Fee Schedule Proposed Rule for CY 2017

Veröffentlicht am von christine.stump@joimax.com

Baltimore, MD – July 14, 2016– The Centers for Medicare & Medicaid Services (CMS) recently released the proposed rules for the 2017 Medicare Physician Fee Schedule (MPFS) and the 2017 Hospital Outpatient Prospective Payment System (HOPPS). Both proposed rules provide information on physician and hospital payment for the newly created CPT code 630X1 for endoscopic decompression of the lumbar spine.

“This is a great step towards the acceptance of endoscopic minimally invasive spine surgery techniques and their benefits to both the surgeon and their patients in the U.S.,” said Wolfgang Ries, Founder and CEO of joimax®. This announcement is in alignment with the reimbursement decision of NICE, UK, in April of 2016, to fully reimburse endoscopic procedures.

A key reason for the recent momentum for endoscopic, minimally invasive spinal surgery is the significant, favorable base of literature, which validates evidence of the efficacy of endoscopic minimally invasive spine surgery. A special edition, “Neurosurgical Focus”, published by the Journal of Neurosurgery (JNS) in February 2016, contains a range of studies on endoscopic spine surgery.

joimax® at the early summer congresses: SpineWeek Amsterdam and DGNC Leipzig

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, 20 March 2012. Right on time with the start into a new decade of the joimax® history, the Karlsruhe-based medical technology company specializing in endoscopic resp. micro-invasive spine surgery will be present at two renowned congresses in March: ISASS from 20 to 23 March 2012 in Barcelona und EndoVienna from 29 March to 1 April 2012 in Vienna.

For the 12th Annual Meeting of ISASS (International Society for the Advancement of Spine Surgery) joimax® will take part in the exhibition and offer an industry workshop with the motto „Endoscopic Spine Surgery – Following New Paths in Barcelona“. Speakers at this event on 21 March 2012 will be Dr. Choll Kim, San Diego, focussing on the outstanding advantages of endoscopic access techniques especially in the area of the lumbar spine. Followed by Dr. Michael Schubert, Munich, with a presentation of complex cases, extending procedures from the lumbar to the thoracic spine, and varying the access path from the transforaminal to the interlaminar surgery method with the joimax® instrument systems TESSYS® und iLESSYS®.

joimax® displays the complete product range for endoscopic spinal surgery: Instrument sets for the treatment of disc herniations – with CESSYS® now being available for the cervical spine –, the novel pain therapy product “Multiuse” for endoscopic facet joint denervation and the iLESSYS® system for 360° decompression. Further special blades for the Shrill® shaver-drill resection and ablation system and namely the Shrill® Deflector Blades for resections „around the corner“, eagerly anticipated by the market, will now be launched.

Preluding the 5th World Congress for Endoscopic Surgery EndoVienna, joimax® has invited internationally renowned specialists to join a User Meeting with presentations of the joimax® Faculty members and a workshop to be held at the Institute of Anatomy of the Vienna University. The User Meeting will be dedicated to an intense exchange of knowledge and ideas of the most experienced users of the joimax® technologies. It will be followed by the keynote lecture of Prof. Dr. G.J. Groen, Utrecht, „High-Resolution Imaging of the Spine: Key to a Better Insight in 3D Relations Within the Spine“, at the opening session of the EndoVienna congress. The program of the „EndoVienna Spine Session“ on 30 March 2012 offers a whole bunch of scientific presentations on the most recent joimax® products. Members of the international joimax® faculty team will present their experiences when applying the joimax® access and resection systems. This session will be chaired by Univ. Doz. Dr. Sandro Eustacchio from the University Hospital Graz.

joimax® is currently planning its attendance to the upcoming congresses: The 80th Annual Meeting of the AANS in Miami in April at the first place. The BASS Britspine in early May. End of May Spine Week in Amsterdam. To be followed by SFCR in Strasbourg in June – it is the first time that joimax® will participate in this congress of the Society of French Spine Surgeons with an exhibition stand and a workshop. Subsequently the company will promote its technologies at the DGNC congress to be held in Leipzig this time. All events focus on industry exhibitions displaying novel product developments and on scientific presence within the conference programs.

Rapid company growth prompts joimax® Inc. to move its US headquarters to a new, larger state-of-the-art facility

Veröffentlicht am von christine.stump@joimax.com

Irvine, CA – November 5, 2018 – joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, announces the move of its US headquarters to a new 26,000-square-foot facility in Irvine, California, beginning November 5, 2018.
“With the move to the new building, the steadily growing need for endoscopic procedures among patients and physician communities can now be efficiently met,” states Wolfgang Ries, Founder and CEO of the joimax® Group. “Growth requires space — the continued demand in the US market creates a major opportunity which joimax® Inc. is addressing with the expansion of its US organization.”
The new office is located at 140 Technology Drive, Suite 150 in the city of Irvine and includes a brand new training and education center. The center offers a demonstration and wet lab training room displaying all joimax® systems and products, as well as a big audience room for didactics presentations. The first workshop will be held at the center on Nov 30th – Dec 1st, 2018.
In addition, the new facility will handle all corporate and business functions. Over the next year, joimax® Inc. will add more clinical support, marketing, and sales personnel in order to face the fast growing demand for endoscopic spine procedures.

Veröffentlicht in Allgemein

joimax® at the AANS in Washington, D.C.

Veröffentlicht am von christine.stump@joimax.com

From May 2-6, the 83rd American Association of Neurological Surgeons (AANS) Annual Scientific Meeting welcomed more than 3,000 medical attendees to Washington, D.C., to celebrate and reflect on both the history and future of neurosurgery.

The team from joimax® Inc. (Irvine, CA, US) participated in this important event as a corporate partner and showcased its products for minimally invasive spine surgery (MISS). Traffic to the booth was high and the team was very satisfied with the outcome of the meeting. One topic that came up during many discussions with the visiting attendees was the screw-rod system Percusys® for spinal stabilization. The product received 510k clearance in March.

joimax® founder and CEO Wolfgang Ries from Karlsruhe, Germany, was invited as the keynote speaker for the Practical Clinic session “Invention and Innovation in Neuro- and Spine Surgery”. His one hour lecture on the first day of the AANS meeting presented a compelling picture on how joimax® evolved since 2001 when the company was founded. Key products and technologies were presented as well which led to engaged discussions after the lecture. Teodoro Forcht-Dagi, Co-Director of the session, commented: „joimax® is a remarkable example of an innovative start-up company that evolved to a successful mid-size local company. Its efforts to work with surgeons and refine MISS technology for the safety and benefit of patients are admirable. A large part of its success is attributable to the combination of technical quality and meticulous training. The company’s contribution to the development of MISS is huge.”

„The AANS Annual Meeting is extremely worthwhile to be at.” emphasized Wolfgang Ries. “For joimax® it was a great opportunity to interact with neurosurgeons and to discuss our well-established MISS techniques and products – made in Germany.”

joimax® moves into larger premises

Veröffentlicht am von christine.stump@joimax.com

joimax® invests in the future and moves into new offices in the US and in Germany

Irvine, USA / Karlsruhe, Germany – 14. Juni 2010 – The medical devices company
joimax® GmbH is moving into new premises both in Germany and the US. „Growth requires space“ had already been the motto of the last company move back in 2005.
The US market has an enormous growth potential. This is why the subsidiary joimax® Inc. is moving from Campbell to Irvine, California, one of high-tech industry centers in the United States. To meet the growing requirements of the US market the joimax® headquarter in Karlsruhe, Germany is also moving into bigger offices. President and founder Wolfgang Ries states: “This step of expansion was necessary to comply with the growing requirements towards our organisation.” “The new premises are a perfect operational basis to be able to cover the growing demand for joimax technologies in the US“, explains Chip Stevens, CEO of joimax Inc.

The doubling of the operational areas is also a landmark decision with respect to the ongoing product launches of the company. joimax® is preparing the launch of the Shrill® in Europe which will shortly be followed by the US launch. This shaver and drill system for the ablation of bone and soft tissue under endoscopic view will be completed by a new pump system called Versicon® and an HD endoscopy system. Following the motto „joimax goes HD“ the so-called Camsource® HD Twister camera system, new HD flat screen monitors and HD endoscopes will be brought to market.

Veröffentlicht in 2010